‘Techno-Optimism’ is Not Something You Should Believe In
By Jag Bhalla & Nathan J. Robinson,
Current Affairs
| 10. 20. 2023
Henk Caspers/Naturalis Biodiversity Center, CC 3.0
Techno-optimism is a dangerous philosophy whose adherents espouse the blind faith that market capitalism and technology will solve the world’s problems. In reality, this kind of optimism simply justifies elite power and promotes indifference to human suffering.
Billionaire tech investor Marc Andreessen recently published a manifesto for “techno-optimism,” a worldview that contends technology will solve all of humanity’s problems and create a world of infinite abundance for all. Andreessen’s manifesto is so extreme that it has been heavily criticized even in the tech sector. It accuses anyone who opposes the unrestricted development of AI of having blood on their hands (since AI will save lives, meaning that if you slow down its development, you are essentially a murderer). It quotes favorably from Italian fascist Filippo Tommaso Marinetti in envisioning a race of technologically-augmented “supermen” and “conquerors.” It condemns “socialism” in favor of “merit and achievement” and treats “social responsibility,” “trust and safety,” “risk management,” and even “sustainable development goals” as “enemy” ideas.
Andreessen’s manifesto comes across as unhinged and manic. It is, in fact...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...